Article
Hsp110 mitigates α-synuclein pathology in vivo
4 Nov 2019
Abstract excerpt
Parkinson's disease is characterized by the aggregation of the presynaptic protein α-synuclein and its deposition into pathologic Lewy bodies. While extensive research has been carried out on mediators of α-synuclein aggregation, molecular facilitators of α-synuclein disaggregation are still generally unknown. We investigated the role of molecular chaperones in both preventing and disaggregating α-synuclein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
